KDOAM-25 T11751
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
KDOAM-25 increases global H3K4 methylation at transcriptional start sites and impairs proliferation in multiple myeloma MM1S cells.KDOAM-25 is a potent and highly selective histone lysine demethylases 5 (KDM5) inhibitor with IC50s of 71 nM, 19 nM, 69 nM,
CAS nr:
2230731-99-2
Purity:
98%
Molecular Weight:
307,39
SMILES:
NC(C1=CC=NC(CNCC(N(CC)CCN(C)C)=O)=C1)=O
Formula:
C15H25N5O2
Pathway:
Microbiology/Virology
Target:
Antibacterial
